PSMA PET Imaging for Prostate Cancer Patient Education - Robert Flavell
January 6, 2021
In this special patient-centered educational video from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Robert Flavell, an Assistant Professor and the Chief of Molecular Imaging and Therapeutics at the University of California in San Francisco presents on PSMA PET imaging. Dr. Flavell's lecture focuses on how PSMA PET is used in diagnosing prostate cancer and presents a case study of PSMA PET showing how it can help individual patients.
Biographies:
Rob Flavell, MD, Ph.D., Assistant Professor, Section Chief, Molecular Imaging and Therapeutics, Radiology and Biomedical Imaging, University of California, San Francisco.
Biographies:
Rob Flavell, MD, Ph.D., Assistant Professor, Section Chief, Molecular Imaging and Therapeutics, Radiology and Biomedical Imaging, University of California, San Francisco.
Related Content:
Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell
Introduction to PET PSMA Gallium-68 PSMA-11 for Diagnostic Imaging of Prostate Cancer - Tom Hope
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell
Introduction to PET PSMA Gallium-68 PSMA-11 for Diagnostic Imaging of Prostate Cancer - Tom Hope
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
Read the Full Video Transcript